US 12102646
Compositions for the treatment of fibrosis and inflammation
granted A61KA61K31/167A61K31/198
Quick answer
US patent 12102646 (Compositions for the treatment of fibrosis and inflammation) held by Viking Therapeutics, Inc. expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viking Therapeutics, Inc.
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/167, A61K31/198, A61K31/222, A61K31/404